The LSE cap is designed to ensure that all biohazard contamination is kept inside the container.
The gripping surface and 360 rotatable nozzle is designed to accommodate different surgical sites.
LSE is designed with lay flat orientation which allows for the device to remain on the surgical table
The LSE-01, is a double patented FDA medical device, that aids surgeons in providing a safe, effective way to remove gelatinous materials, and similar surgical substances, from the body or surgical site.
A LaRue Company has plastic surgery professionals in Texas, Arkansas, and North Carolina providing valuable feedback from clinical testing. The small surgeon survey performed by A LaRue Company shows 9 out of 10 doctors would purchase the LaRue Surgical Evacuator to aid in the removal of ruptured implants.
Smaller incision sizes when removing large implants.
IF the implant is ruptured before or during surgery, the LSE is the fastest, most complete way to remove loose silicone.
If a total capsulectomy is not possible because the capsule is too close to the lungs, the LSE can remove the implant allowing the surgeon to remove as much of the capsule as possible.
When performing a total capsulectomy with fragile and easily broken capsules, the LSE will remove the implant and the capsule contents quickly and efficiently. The surgeon will be able to remove and visualize the capsule more completely.
When performing En bloc with total capsulectomy, use of the LSE and "Clean Removal Process" helps ensure any leaked silicone has been removed and the surgical site is as “clean” as possible. Provides confidence that every effort has been made for a complete removal.
Using the LSE reduces the possibility of reintroduction of silicone into the Breast pocket by keeping the surgeon from touching the implant or silicone that has leaked from the implant. The LSE minimizes exposure to harmful biohazards.
The LSE “Clean Removal Process” can reduce time and increase efficacy to surgeons while providing patients a safe, rapid, and less invasive Explant procedure, minimizing the surgical teams exposure to harmful biohazards, simultaneously providing better outcomes to the patient.
The FDA has been bombarded with complaints from women who say that breast implants make them sick. Many women are concerned that their breast implants may be leaking silicone into their bodies. Silicone can migrate to a patient's lungs, liver, or other organs where surgeons cannot retrieve it.
As a result, some studies have been conducted regarding the health consequences of breast implants and the best practices for treating ruptured breast implants. Still, more evidence is needed to provide a consensus on how breast implants affect a patient's health. Initial studies offer proof that removing breast implants in a no-touch method should be the standard of care that ensures the most silicone removal with the best results for a patient's health.
As a response in late 2021, the FDA placed a black box warning on breast implants, added new breast implants' sale restrictions, and called for post-approval surveillance studies by implant manufacturers.
One out of every four women has breast implants, and the rupture leaking rate of breast implants is as high as 43.9%.
A LaRue Company
1940 Ironstone Court, Winston Salem, NC 27127, US
Copyright © 2023 A LaRue Company - All Rights Reserved.
Powered by GoDaddy